SmithKline Beecham Corporation and SmithKline Beecham p.l.c.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 29, 2007 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 26 Total Citation Count
- Jul 20, 2001 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2004/0141,964 Recombinant IL-18 antagonists useful in treatment of IL-18 mediated disordersAbandonedJan 22, 04Jul 22, 04[A61K]
2003/0203,917 Compounds and methods for the treatment of neoplastic diseaseAbandonedMay 20, 03Oct 30, 03[A61K]
2003/0157,169 Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-az-abicyclo[2.2.2]oct-3-yl)acetonitrile monohydrochlorideAbandonedAug 28, 02Aug 21, 03[A61K]
2002/0137,054 AXOR35, a G-protein coupled receptorAbandonedJul 20, 01Sep 26, 02[C07H, C12Q, C12P, C12N, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.